Enzymit

About:

Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free’ enzymatic manufacturing technology

Website: https://www.enzymit.com/

Twitter/X: enzymit

Top Investors: Khosla Ventures, Israel Innovation Authority, First Star Ventures, MassChallenge, NextLeap Ventures

Description:

Enzymit's vision is to transform global manufacturing by eliminating dependence on scarce resources through local, sustainable, affordable bio-production. Enzymit is developing cell-free bio-production, the next generation of bio production technology eliminating the inefficiencies, complexity and cost of current bio-production technologies. Enzymit’s small, modular bio-reactors can efficiently convert available and abundant feedstocks into valuable products, from pharmaceuticals and cosmetics to food and materials. We are offering global resource independence while reducing the environmental impact. Enzymit uses artificial intelligence to design new-to-nature enzymes, the molecular machines in living cells that perform life-enabling functions. Our novel enzymes create molecular assembly lines that transform any feedstock into desired products. This approach reimagines bio-production by moving away from traditional, complex, and costly whole-cell methods to using nature’s elemental building blocks, making bio-production competitive with traditional chemical manufacturing in cost, efficiency, and sustainability, while also offering greater flexibility in product customization.